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Abstract
Nanotechnology is expected to play a vital role in the rapidly developing field of nanomedicine, creating innovative
solutions and therapies for currently untreatable diseases, and providing new tools for various biomedical applications, such
as drug delivery and gene therapy. In order to optimize the efficacy of nanoparticle (NP) delivery to cells, it is necessary to
understand the mechanisms by which NPs are internalized by cells, as this will likely determine their ultimate sub-cellular
fate and localisation. Here we have used pharmacological inhibitors of some of the major endocytic pathways to investigate
nanoparticle uptake mechanisms in a range of representative human cell lines, including HeLa (cervical cancer), A549 (lung
carcinoma) and 1321N1 (brain astrocytoma). Chlorpromazine and genistein were used to inhibit clathrin and caveolin
mediated endocytosis, respectively. Cytochalasin A and nocodazole were used to inhibit, respectively, the polymerisation of
actin and microtubule cytoskeleton. Uptake experiments were performed systematically across the different cell lines, using
carboxylated polystyrene NPs of 40 nm and 200 nm diameters, as model NPs of sizes comparable to typical endocytic
cargoes. The results clearly indicated that, in all cases and cell types, NPs entered cells via active energy dependent
processes. NP uptake in HeLa and 1321N1 cells was strongly affected by actin depolymerisation, while A549 cells showed a
stronger inhibition of NP uptake (in comparison to the other cell types) after microtubule disruption and treatment with
genistein. A strong reduction of NP uptake was observed after chlorpromazine treatment only in the case of 1321N1 cells.
These outcomes suggested that the same NP might exploit different uptake mechanisms to enter different cell types.
Citation: dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA (2011) Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene
Nanoparticles in Different Cell Lines. PLoS ONE 6(9): e24438. doi:10.1371/journal.pone.0024438
Editor: Joel M. Schnur, George Mason University, United States of America
Received February 4, 2011; Accepted August 10, 2011; Published September 19, 2011
Copyright:  2011 dos Santos et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was performed within the scope of an SFI RFP (CHP031, Dr. dos Santos) and the EU FP6 project NanoInteract (NMP4-CT-2006-033231, Dr.
Salvati). The SFI SRC BioNanoInteract (07 SRC B1155) also supported the research reported here. Additional financial support from FP6 IST project SIGHT (IST-2005-
033700, Dr. Varela) and the SFI RFP (MTR2425, Dr. Varela) is acknowledged. The ESF Research Networking Programme EpitopeMap is also gratefully acknowledged
for funding an exchange trip to Dr. dos Santos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Tiago.Santos@cbni.ucd.ie (TdS); Kenneth.a.dawson@cbni.ucd.ie (KAD)
Introduction
Nanomedicine is the application of nanotechnology in innova-
tive ways to develop new approaches and therapies for treatment
of diseases, including drug delivery and gene therapy [1–6]. In
order to utilise NPs to deliver drugs to a target organ or cellular
location more effectively, it is essential, as a first step, to
understand the distinct endocytic mechanism(s) used by the
specific NPs to enter the target cells. From this information, it
may be possible to develop approaches to enable NPs to escape the
acidic pathway, which often leads NPs to a final localisation in the
lysosomes, which is the cellular waste bin [7]. Thus, therapeutic
NPs would be much more effective if they could be designed to
reach the nucleus (gene therapy) or other organelles involved in
disease progression, and if they could deliver their payload directly
to the site of action. So far, several distinct cellular uptake
pathways for drugs, protein-lipids clusters, virus and bacteria have
been described [8–12], and many attempts have been made to
classify and characterize them, typically according to the proteins
involved at the early stages, or via the size of the entities that they
take up into cells [13].
Briefly, some aspects of the different uptake pathways are
summarised here.
Phagocytosis is restricted to specialized mammalian cells such as
neutrophils, monocytes and macrophages, which function to
engulf and digest cellular debris and pathogens, and are essential
to keep the immune system in a clean and sterile state. Interaction
of a pathogen with specific cell surface receptors induces signalling
cascades mediated by Rho-family GTPases, triggering polymer-
ization of actin membrane protrusions at the site of ingestion. After
internalisation, actin is shed from the phagosome, and a series of
fusion and fission events, involving components of the endocytic
pathway, culminates in the formation of the mature phagolyso-
some [14]. Although this process is mainly present in specialised
cells, it is known that non-specialised cells can, in rare situations,
retain the ability to activate uptake processes which resemble
phagocytosis [15].
Other well characterised uptake pathways include: (i) Clathrin-
mediated endocytosis (CME), which is a process involving specific
receptors that recognize and internalize cargo into ‘‘coated pits’’,
formed by the assembly of a cytosolic coat protein, clathrin, which
constitutes the main assembly unit. These coated pits invaginate
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later mature into late endosomes and fuse with lysosomes. The
literature on these pathways is extensive and the structure of
clathrin and the clathrin coated pits is well resolved, as is the role
of other key proteins involved [16–19]. Typical sizes of clathrin
coated pits are in the range 60–200 nm diameter [20,21]. (ii)
Caveolae-mediated endocytosis, which involves clustering of lipid
raft components on the plasma membrane into so called caveolae,
which are flask-shaped invaginations, formed as a result of the
interactions of different proteins, mainly caveolin, with the cellular
membrane. Caveolae are extremely abundant at the surface of
endothelial cells, and internalisation via this pathway is induced by
specific ligands such as cholera toxin and simian virus-40, and this
is considered to be the predominant pathway of entry for particles
above 200 nm [20,22,23]. (iii) Other uptake pathways have been
classified as clathrin- and caveolae-independent endocytosis. For
these pathways, other types of cholesterol-rich microdomains on
the plasma membrane are involved, rather than caveolae. These
domains are generally referred to as lipid rafts, small structures of
40–50 nm in diameter, that diffuse on the cell surface [24–26].
These small rafts can be captured by, and internalized within, an
endocytic vesicle and although the regulatory mechanisms for
these pathways are still unknown, these alternative endocytic
carrier vesicles are known to be rich in glycosyl phosphatidylino-
sitol (GPI)-anchored protein, and can end in the Golgi complex or
in recycling endosomes [27,28]. Literature is growing on these
pathways, where specific classes of lipids have been reported to
induce membrane curvature to allow the invagination of the
plasma membrane, in the absence of proteins like clathrin and
caveolin to facilitate the process [29,30]. (iv) Finally, macro-
pinocytosis involves the internalisation of large areas of the plasma
membrane together with significant amounts of fluid, since
uncoated vesicles can be bigger than coated ones, thus allowing
endocytosis of larger objects (.150 nm). Actin membrane
protrusions caused by extensive actin rearrangement, which are
triggered by the stimulation of Rho-family GTPases, are a
fundamental part of this process [31,32].
Fundamental questions in the study of the interactions of NPs
with cells include whether, and how, NPs map onto these pre-
existing cellular uptake mechanisms. As a result of their nanoscale
size, which is similar to that of many of the protein-lipid clusters
(lipoprotein complexes) routinely transported into and out of cells,
and their ability to interact with lipoproteins [33,34], NPs are now
known to have the ability to enter cells, interacting with the
cellular machinery through active, energy-dependent processes
[7,35–42].
In the present paper, we seek to investigate by which endocytic
mechanism(s) negatively charged carboxylated-modified polysty-
rene NPs, of two sizes representative of typically endocytotic
cargoes (40 nm, 200 nm), are internalized by a panel of different
cell types, including HeLa tumoral epithelial cells from Cervix,
commonly used to study cell biology of uptake mechanisms [43–
45], A549 endothelial cells from lung carcinoma, widely applied
in toxicity studies for lung exposure scenarios [46,47], and
1321N1 (glial cells from brain astrocytoma), which are a good
model for impact in the central nervous system [48,49]. The
uptake of the model polystyrene NPs was systematically studied in
the presence and absence of a series of pharmacological inhibitors
of different aspects of endocytosis. Despite showing poor
specificity, these tools are useful and widely used in cell biology,
and are now being applied to the question of NP-cell
interactions[18,50,51]. The inhibitors used in this work were:
genistein, an inhibitor of tyrosine kinases involved in caveolae-
mediated endocytosis [52,53]; chlorpromazine, which inhibits
clathrin disassembly and receptor recycling to the plasma
membrane during clathrin-mediated endocytosis [54]; nocoda-
zole, a microtubule-disrupting agent [55,56]; and cytochalasin A,
an actin-disrupting agent that is used widely to study the role of
actin filaments in different biological systems. The efficacy of the
inhibition of NP uptake in the different cell lines was quantified
by flow cytometry relative to the control cells in the absence of
the pharmacological inhibitors.
Results and Discussion
Carboxylated-modified polystyrene (PS-COOH) NPs with
nominal sizes of 40 nm and 200 nm were chosen as model
particles in order to understand the mechanism of internalisation
in different cell lines, due to their wide availability to the scientific
community, and the fact that they are fluorescently labeled in a
manner that we have previously shown is suitable for uptake
studies (i.e. they do not elute significant quantities of free dye
under cell culture conditions over the timescale of uptake studies)
[42]. We focused the work on these NP sizes, as being
representative of typical naturally occurring ‘‘nanoparticles’’ such
as low-density lipoprotein (LDL), very-low-density lipoprotein
(VLDL) etc (which have a diameter around 30–50 nm) and larger
objects which are, however, still below the limit of specialized
phagocytosis [8,10,13,57]. Electron Microscopy studies on the
same NPs confirmed that the manufacturer’s stated particle sizes
corresponded mainly to their nominal size [58]. As reported in
Table 1, the particles were monodisperse in size when measured
in PBS buffer, and no strong aggregation was found when
particles were dispersed in complete MEM medium (cMEM
supplemented with 10% foetal bovine serum, FBS). Zeta potential
measurements in Dulbecco’s Phosphate Buffered Saline (DPBS)
and cMEM, showed that the particles have a negative surface
charge, with a zeta potential of 226 mV and 228 mV for the
40 nm and 200 nm PS-COOH NPs respectively in PBS, which
decreased to 210 mV and 23 mV respectively in cMEM, due to
serum protein adsorption onto the NPs. The lower zeta potential
in cMEM did not result in NP instability and aggregation,
probably due to steric hindrance from the proteins adsorbed on
the NP surface in cMEM. All cellular studies were performed
using the full panel of cell lines. Flow cytometry has been used to
measure average cell fluorescence intensity after uptake of 20 mg/
mL fluorescently labeled NPs. A typical profile of uptake as a
function of exposure time is shown in Figure S1 for the two NPs
used in this study in HeLa cells, together with representative
confocal images of cells treated in the same way, which confirmed
that the NPs accumulate inside the cells. Similar profiles have
been obtained for all the investigated cell lines (data not shown)
and indicate that cell fluorescence increases with time, as NPs
accumulate in the cells (having confirmed the absence of free dye
that elutes from the particles) [42]. We then compared the cell
fluorescence levels at a given NP exposure time (2 h) in the
absence or presence of the different transport inhibitors (see
Materials and Methods for details). Thus, we report the results as
the percentage of NP uptake in cells treated with the different
inhibitors, with respect to NP uptake in untreated (normal)
control cells. This also implies that the results are not affected by
the different fluorescence intensities of the two different NP sizes.
It is important to stress that the exposure protocols (as detailed in
the Methods section) have been designed to ensure control of
each step: Figure S2 shows, as an example, the optimization
performed to ensure particle removal from the external side of
the cell membrane, prior to cell fluorescence assessment by flow
cytometry.
Effects of Transport Inhibitors on NP’s Uptake
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inhibition of the uptake of PS-COOH NPs
In order to determine whether NP uptake was an active or
passive process, cell cultures were incubated in parallel at 37uC
(normal cell culture conditions) and at 4uC. It is known that several
proteins and enzymes are sensitive to temperature, thus active
processes are inhibited by lowered temperatures [59,60]. Exposure
to NPs at 4uC resulted, as expected, in a very strong inhibition of
endocytosis of both particle sizes in all three cell types (Figure 1): in
HeLa cells, the average cellular fluorescence was reduced by about
80% for the 40 nm particles and 60% for the 200 nm NPs, in
respect to the uptake at 37uC; in A549 cells the uptake was
reduced by about 90% and 70% respectively for the 40 nm and
200 nm particles, and for 1321N1 cells 82% and 62% respectively.
Similar experiments with SiO2 NPs of several sizes showed the
same behavior, with NP uptake being highly energy dependent
[7]. Although lowering the culture temperature will affect the
diffusion of the NPs, we have demonstrated previously that
diffusion is not the rate limiting step for NP uptake in cells [42],
and thus we can confirm that the reduced uptake is a consequence
of inhibition of active transport, rather than a consequence of
reduced NP diffusion (the same applies for the different diffusion
rates of NPs of different sizes). Moreover, a trend in the inhibition
for the different particle sizes can be recognized for all cell lines,
with the uptake of the smaller particles (40 nm PS-COOH)
showing a stronger reduction in energy depleted conditions,
compared with that of the 200 nm PS-COOH NPs.
One important requirement when using endocytosis inhibitors
(genistein, chlorpromazine, and nocodazole) is that they should not
affect the actin cytoskeleton, since reorganization of the actin
filaments may, as a side effect, impact on uptake processes which
do not directly involve actin and may alter the function of various
plasma membrane proteins [61–63], thereby confounding the data
and leading to multiple effects occurring simultaneously. Figure 2
showstheorganizationoftheactinfilamentsintheA549celllineafter
2 h of treatment with each of the four inhibitors used in the study (no
NPs present). Even though these inhibitors always affect the cell
population viability (as discussed further below), we can observe that
the actin filaments maintain their overall structure when exposed to
each of the inhibitors used, with the exception of cytochalasin A, a
known actin-disrupting agent, which was used with the specific
purpose of investigating the role of actin filaments in NP uptake. A
similar trend was observed in the other celllines (FigureS3aand S3b).
All of the inhibitors were used according to the manufacturer’s
protocols, which are also frequently reported in the literature for
different cell lines in order to achieve transport inhibition [64–66].
When possible, transport of molecules known to selectively enter cells
via a specific pathway were used as positive controls to confirm that
the required inhibition was achieved, such as transferrin and cholera
toxin B for clathrin and caveolae mediated endocytosis, respectively
(as shown in Figure S4). However, this was not possible in all cases
due to the lack of specificity of these molecules.
NP uptake was measured only at short exposure times, since it
has been previously reported that blocking one uptake pathway
can result in activation of other endocytic mechanisms, which
again confounds the data [67]. Thus, a balance must be found
between allowing sufficient time for detectible levels of NPs to
enter the cells, and for the transport inhibitors to reduce
endocytosis, without inducing too-severe side effects in terms of
toxicity from these molecules. On this basis, it is also essential to
evaluate the cellular toxicity of each of the pharmacological
inhibitors, as a quality control step prior to their co-incubation
with the NPs. Thus, the cell viability of each of the cell lines was
assessed after 2 h of exposure to each of the different inhibitors, by
measuring ATP levels and by propidium iodide (PI) staining. PI
only penetrates cells with increased cell membrane permeability,
thus accumulates in apoptotic or necrotic cells, and thereby the
percentage of PI positive cells, which can be assessed by flow
cytometry, can be used as a measurement of cell damage. Results
are shown in Figure 3 and indicated that no strong cell damage
and cell loss after treatment with the four different pharmacolog-
ical inhibitors was found for all cell lines used in this study.
Table 1. PS-COOH NP characterization in PBS buffer and complete medium (cMEM, containing 10% foetal bovine serum).
Carboxylate modified
polystyrene NPs Mean hydrodynamic diameter (nm)
a PDI
b Zeta Potential (mV)
PBS cMEM PBS cMEM PBS cMEM
PS 40 nm 48615 9 61 0.015 0.123 -2663- 1 0 62
PS 200 nm 247632 6 9 61 0.035 0.061 -2862- 3 67
az-average hydrodynamic diameter extracted by cumulant analysis of the data (number distributions).
bPolydispersity index from cumulant fitting.
Polydispersity index.
doi:10.1371/journal.pone.0024438.t001
Figure 1. Energy dependent internalisation of 40 nm and 200
nm PS-COOH NPs into various cell lines. Cells were pre-incubated
for 30 min at 4uC, and subsequently exposed to the NPs, also at 4uC for
2 h, followed by fixation and FACS analysis. Mean values and standard
deviations of three independent duplicate experiments are given.
doi:10.1371/journal.pone.0024438.g001
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inhibitors are shown in Figure 4 for the different cell lines
investigated (with the results for the 40 and 200 nm PS-CPPH NPs
respectively in panel a and b).
The effect of microtubules and F-actin on the uptake of
PS-COOH NPs
The cytoskeleton plays an important role in multiple cellular
events, including endocytosis and trafficking of endocytosis
vesicles. For this reason, we have investigated the role of two of
the major constituents of the cytoskeleton structure, microtubules
and F-actin, in NP uptake and internalisation. Although both
microtubules and F-actin are essential in most of the uptake
mechanisms described above, it is important to evaluate how
strongly NP uptake depends on the presence of these structures. As
mentioned above, cytochalasin A can disrupt F-actin polymeriza-
tion, and as such, has been used to investigate the role of F-actin in
cellular uptake of PS-COOH NPs. As shown in Figure 4a, in the
case of HeLa and 1321N1 cells, cytochalasin A inhibited the
endocytosis of 40 nm PS-COOH particles by about 30% relative
to the control cells. For the 200 nm PS-COOH NPs, the effect of
cytochalasin A was stronger, with a 50% reduction of uptake in
HeLa cells and a 65% reduction of uptake in 1321N1 cells, relative
to the controls (Figure 4b). This suggests a strong involvement of
the actin filaments in the uptake process of PS-COOH NPs in
these cell lines and especially for the larger PS-COOH particles.
Interestingly, results for A549 cells showed a smaller inhibition of
uptake, with only ,20% reduction for both particle sizes,
indicating a smaller dependency of PS-COOH NP uptake on F-
actin for this particular cell line. This result could also be explained
by a different efficiency of the inhibition induced by cytochalasin A
in the different cell lines, however the images shown previously
(Figure 2) seem to exclude this possibility, as strong actin
depolymerisation was evident for all the cells used in the study,
including the A549 cells (Figures 2, S3a and S3b)).
It has been reported that microtubules are also involved in the
endocytic process, and thus nocodazole was used as a microtubule
disruptor in order to assess the influence of microtubules on NP
internalisation by the panel of cells. The effects of this treatment
were not as strong as with actin depolymerisation. Nocodazole was
found to inhibit endocytosis of larger particles (200 nm PS-
COOH) primarily, with the highest inhibition observed in the
A549 cell line, where uptake was reduced by ,40% relative to
control cells (Figure 4b). In the case of HeLa and 1321N1 cells, the
inhibition of uptake of 200 nm PS-COOH NPs was slightly less,
with uptake being reduced by ,20% relative to normal controls
(Figure 4b). For the smaller NPs (40 nm PS-COOH), the
inhibition was only 5–10% relative to the normal control cells in
the case of A549 and 1321N1 cells, and no reduction of uptake
was observed in HeLa cells (Figure 4a). These results suggest that
microtubules are mostly involved in the uptake of larger particles,
and are particularly relevant in the uptake of PS-COOH particles
by A549 cells. These results are in agreement with Dausend et al.
(2008) who found that uptake of 120 nm negatively charged
polystyrene NPs by HeLa cells was not inhibited by nocodazole.
Mechanism of PS-COOH NP internalisation: clathrin vs
caveolin
It is well established that transferrin (Tf) is a ligand exclusively
internalized via the clathrin-coated-pit endocytosis pathway, and
thus its uptake is expected to be affected by treatment with
chlorpromazine, an inhibitor of clathrin-mediated endocytosis. For
this reason, we used transferrin as a positive control to confirm the
inhibition of this particular endocytotic pathway upon treatment
with chlorpromazine [54]. The results are shown in Figure S4 and,
as expected, indicate a very strong reduction of Tf uptake in
chlorpromazine treated cells, thus confirming the applied
inhibition protocol. Treatment with chlorpromazine resulted in a
strong inhibition of PS-COOH NP uptake in the 1321N1 cell line,
with the larger particles having a strong (70%) decrease in uptake,
relative to normal control cells, compared with a 50% inhibition of
uptake for the 40 nm PS-COOH particles (Figure 4). Although
this trend in the level of inhibition for the two PS-COOH particle
sizes was found also in A549 cell line, it is noteworthy that in HeLa
Figure 2. Confocal images of A549 cells showing the F-actin morphology in normal control cells and, following incubation with
each of the different inhibitors at 376Co r4 6C for 2 h30 min. (Blue DAPI stained nuclei, Texas red-phalloidin stained actin filaments,
Magnification 63X). The scale bar corresponds to 20 mm.
doi:10.1371/journal.pone.0024438.g002
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Rejman et al. (2004), using similar negatively charged polystyrene
NPs, with sizes between 50 and 200 nm in B16 cells (mouse
melanoma cell line), showed instead that chlorpromazine treat-
ment affected more strongly the uptake of the smaller NPs, which
is the opposite to what we found in the cell lines used in this study.
Moreover, Dausend et al. (2008) showed no significant inhibitory
effect of chlorpromazine on the uptake of 120 nm negatively
charged polystyrene NPs by HeLa cells.
As described above, receptor-associated tyrosine-specific protein
kinases are reported to be involved in lipid raft-dependent
endocytosis, thus genistein, which is a specific inhibitor of these
proteins, can be used to study the involvement of lipid raft-
dependent uptake mechanisms in the uptake of PS-COOH NPs by
our panel of cells. It is noteworthy that the concentration of
genistein applied in the present study was not sufficient to
significantly inhibit the uptake cholera toxin B (also shown in
Figure S4). This confirms a major problem for this kind of
pharmacological drug, which is the lack of specific positive controls
for each of the distinct endocytic pathways [68]. However NP
internalisation was strongly reduced by genistein in A549 cells
(Figures 4a and 4b), especially for the 200 nm PS-COOH NPs, with
a decreaseintheuptakeof50%relative tonormal controlcells.This
suggests that there is a strong participation of lipid raft-associated
receptors in the endocytosis of the 200 nm PS-COOH particles for
this cell line. In addition, we can again observe a trend for the
different cell lines, with a higher inhibition for the bigger (200 nm)
particles, when compared to the 40 nm PS-COOH NPs. These
results are in agreement with Rejman et al., who suggested that
caveolae flask-shaped invaginations are able to internalize larger
Figure 3. Cell viability as determined by a) ATP assay to measure ATP content in cells and b) propidium iodide staining as a
measure of membrane damage, following exposure to each one of the different inhibitors for 2 h30 min. Results are presented as a
percentage of ATP levels and PI positive cells, with respect to control (untreated) cells, averaged between 2 independent replicas of 3 independent
experiments.
doi:10.1371/journal.pone.0024438.g003
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restricted by the triskeletal structure of clathrin). Although lacking a
clear mechanistic explanation as yet, electrostatic interactions and
kinetics of internalisation could explain why, despite the size of the
caveolae being normally 60–80 nm, genistein has such a big effect
in the uptake of 200 nm NPs.
A summary of all the results obtained with the different
transport inhibitors in the different cell lines is given in Table 2,
together with some of the results available in the literature for
similar systems. The levels of inhibition of uptake (NPs and
positive control molecules) observed with the different drugs are
presented there as a percentage with respect to the uptake
obtained in normal cells exposed to NPs (or to positive control
molecules) under the same conditions (so that the level of
inhibition in normal control cells is 0%).
Different outcomes were observed across the different cell lines
and in several cases the treatment with the inhibitors showed only
a small effect on nanoparticle uptake. In the case of HeLa cells, the
strongest effects were observed after depolymerisation of the actin
filaments by treatment with cytochalasin A, suggesting a central
Figure 4. Effect of transport inhibitors on the internalisation of a) 40 nm and b) 200 nm PS-COOH NPs into the various cell lines.
Cells were pretreated with each one of the inhibitors (cytochalasin A, nocodazole, chlorpromazine and genistein) for 30 min, followed by 2 h of
exposure to the NPs, in the presence of the same inhibitor, then fixed and analyzed by FACS. Mean values and standard deviations of three
independent duplicate experiments are given. Results are reported as the percentage of uptake relative to untreated cells exposed to NPs. This was
calculated by dividing the cell fluorescence after NP uptake in drug treated cells by that of control cells which were not treated with the inhibitors.
doi:10.1371/journal.pone.0024438.g004
Table 2. Levels of inhibition of the uptake of 40 nm and 200 nm PS-COOH nanoparticles (and positive controls) in cells exposed to
the different inhibitors in respect to the uptake in untreated cells.
Level of inhibition (%) relative to control
Cytochalasin A Nocodazole Chorpromazine Genistein 46C
HeLa 40 nm NPs 34690 692 3 617 618 0 61
200 nm NPs 5263 (50)[45] 17610 (0)[45] 2661 (0)[45] 30676 0 61 (60)[45]
Transferrin - - 9461 (80)[45] - -
Cholera toxin B - - - - -
A549 40 nm NPs 17668 632 3 682 4 639 0 62 (70)[7]
200 nm NPs 23610 40654 3 655 0 610 706 3 (70)[7]
Transferrin - - 90 - -
Cholera toxin B - - - 14616 -
1321N1 40 nm NPs 33611 3 610 47611 9 638 2 65
200 nm NPs 66632 0 6 9 3 3 626 2 62
Transferrin - - 96 - -
Cholera toxin B - - - - -
Results are presented as a percentage in respect to the uptake in normal (untreated) cells under the same conditions and averaged between 2 independent replicas of 3
independent experiments. In italic and brackets some comparative data from experiments performed by other researchers, in similar systems, with respective
references.
doi:10.1371/journal.pone.0024438.t002
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several endocytic pathways, including clathrin mediated endocy-
tosis, however the chlorpromazine treatment, which also affects
this pathway, did not inhibit NP uptake in HeLa cells to a similar
extent. In 1321N1 cells, NP uptake was also strongly affected by
actin depolymerisation. These cells showed a significant inhibition
of NP internalisation after treatment with chlorpromazine for both
investigated particle sizes, with stronger effects being observed for
the larger particle size, suggesting that both actin and clathrin
might be implied in the NP uptake mechanisms. Finally, the A549
cells were the least affected by actin depolymerisation, while only
for this cell type NP uptake was affected by microtubule
depolymerisation and treatment with genistein to a small extent.
This suggests a bigger role of microtubules and lipid rafts for NP
internalisation in A549 cells, with the stronger effects observed,
also in this case, for the larger particle size.
In conclusion, NPs have the capacity to interact with the cellular
machinery and can enter very different cell types with ease. The
data presented here highlight the complexity and interplay between
the mechanisms by which different cell lines are able to endocytose
NPs, and suggest that the same NP might be internalised via
different pathways in different cell types. NP uptake was most
effectively reduced when active processes were inhibited, and this
indicated that cells need to spend energyin order to internalize NPs.
None of the pharmacological treatments could fully inhibit NP
uptake and this leaves open the possibility that within one cell type,
they use multiple pathways simultaneously to internalise the same
NP. The results clearly indicate the importance of careful analysis
and individual interpretation for each cell-NP system, and the need
to build up a database of information regarding the responses of
different cell types to common NPs, in order to begin to construct
patterns and trends in cellular responses to NPs. It is clear that great
care and significant additional work must be undertaken in order to
be able to fully investigate NP uptake mechanisms and to safely use
NPs for nanomedicine applications.
Materials and Methods
Cell culture
Human glial astrocytoma 1321N1 cells (passage 2–10 after
defrosting from liquid nitrogen)were cultured at 37uCi n5 %C O 2
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 10% foetal bovine serum (FBS, Gibco) and 1% penicillin/
streptomycin (Invitrogen Corp.).
Human lung epithelium A549 cells (passage 1–30 after
defrosting from liquid nitrogen; original batches at passage
number 105 or 82) were cultured at 37uCi n5 %C O 2 in
Minimum Essential Medium (MEM, with additional L-Gluta-
mine) supplemented with 10% foetal bovine serum (FBS, Gibco),
1% penicillin/streptomycin (Invitrogen Corp.), and 1% MEM
non-essential amino acids (HyClone).
Human cervix epithelium HeLa cells (passage 5–10) were
cultured at 37uCi n5 %C O 2 in Minimum Essential Medium
(MEM, with additional L-Glutamine) supplemented with 10%
foetal bovine serum (FBS, Gibco) and 1% penicillin/streptomycin
(Invitrogen Corp.).
All cell lines were confirmed to be mycoplasma negative using
the mycoAlert kit (Lonza Inc. Allendale, NJ) and were tested
monthly.
Nanoparticles
Red dye-loaded (Excitation/Emission wavelengths: 580–605)
carboxylate-modified polystyrene NPs (FluospheresH size kit,
Invitrogen) were used without further modification or purification.
Sizes used in this work were 40 nm, 200 nm. All stock solutions
were stored at 4uC, and used within 1 year of purchase, in order to
ensure their stability.
NP dispersions were prepared by diluting the concentrated stock
solutions into the complete medium (cMEM) used for cell culture
at room temperature, with or without inhibitor drugs, immediately
prior to the experiments on cells, with an identical time delay
between diluting and introducing to the cells for all experiments.
The medium was kept at room temperature and not pre-warmed
to 37uC to ensure better NP dispersions. Before sampling, NPs
were vigorously mixed by vortexing, as recommended by the
company.
The mean size and surface charge of NPs were determined
using a photon correlation spectrophotometer (Malvern Zetasizer
Nano ZS). Measurements were performed at 25uC in DPBS and
in MEM. The particle size distribution and zeta potential data are
presented in Table 1.
Flow cytometry analysis of NPs uptake: energy
dependence and inhibition
1.25610
5 cells were seeded in individual 30 mm tissue culture
dishes (Greiner Bio-one), and incubated for 24 h prior to addition
of particles. Each step from NP exposure to cell to sample
preparation for flow cytometry has been optimized in order to
ensure reproducibility of the data and quantitative information to
be obtained. Several artifacts could arise from this kind of
experiments without such optimizations and control. Thus, after
24 hrs, cells were pre-incubated for 30 min with the different
drugs at the following concentrations: chlorpromazine hydrochlo-
ride 10 mg/ml, cytochalasin A 5 mg/ml, genistein 200 mM and
nocodazole 20 mM (all from Sigma). Energy dependence exper-
iments were performed by pre-incubating the cells at 4uC for
30 min prior to exposure to NPs. After this pre-incubation, NPs
(final concentration 20 mg/ml) were added and incubated for
120 min, either in the presence of the drugs or at 4uC. Negative
controls, i.e., cells without the presence of drugs and/or NPs were
also carried out. After this incubation time, the medium was
removed and the samples were washed with DPBS, in order to
ensure particle removal from the outer cell membrane. As an
example of the protocol optimization, figure S2 shows the
fluorescence intensity of several PBS washes of the cell plate,
following particle removal. The results indicated that a significant
residual amount of NP could be detected in the first washes after
particle removal. Thus we set the number of washes with PBS to a
minimum of 3, to optimally remove NPs adhering on the cell
membrane or on the plate, which could affect following steps and
the quantification of cell fluorescence intensity by flow cytometry.
Cell were then harvested with 0.05% trypsin/EDTA 1x, and cell
pellets were fixed with 4% formalin solution neutral buffered
(Sigma) for 20 min and re-suspended with constant volumes of
DPBS before cell-associated fluorescence (10,000–40,000 cells per
sample) was detected using a CyAn ADP (DAKO) flow cytometer.
In all the cases, to ensure reproducibility, the waiting time between
sample preparation and measurement was kept constant, at a
minimum of 1.5 h, to ensure complete stability of the sample.
Strong modifications of the side scattering, forward scattering and
fluorescence intensities were detected in the 1st h, after which all
these parameters were more constant with time, but still changing
slightly. Samples were stored in darkness at 4uC before
measurements. The results are reported as the mean of the
distribution of cell fluorescence intensity obtained by measuring
15000 cells, averaged between 2 independent replicas of 3
independent experiments. Error bars are the standard deviation
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carried out in the Flow Cytometry Core Facility at the Conway
Institute, University College Dublin.
Cell viability in the presence of the inhibitors: ATP and
propidium iodide assays
Cells were seeded in white, clear bottomed 96 well micro-assay-
plates, (Greiner bio-one) at 10
4 cells/100 ml/well (n=6) and
incubated for 24 h. After 24 hrs, cells were incubated for
120 min with 50 ml of medium containing one of the inhibitors
at the concentrations mentioned above. Normal cells were used as
the negative control. ATP content was measured in accordance to
the protocol of the CellTiter-GloTM luminescent cell viability
assay kit (Promega). Briefly, 50 ml of assay reagent was added to
the wells and mixed for 2 min at room temperature. After 10 min,
intracellular ATP content was measured using a Varioskan Flash
plate reader (ThermoFisher Scientific). Normalisation of ATP
content was calculated using the following equation: Normalised
ATP content (in percentage) = [value (cells exposed to drug)/
value (cells untreated with drugs)]6100. For the propidium iodide
assay, 1.25610
5 cells were seeded in individual 30 mm tissue
culture dishes (Greiner Bio-one), and incubated for 24 h prior to
addition of drugs. After 24 hrs, cells were incubated for 120 min in
the presence of one of the drugs at concentration described before.
After this incubation time, the medium was removed and the
samples were washed thrice with DPBS and harvested with 0.05%
trypsin/EDTA 1x. Cell pellets were re-suspended with 0.5 ml of
DPBS and kept ice-cold until measurements were performed. 5 ml
of propidium iodide was added per sample, and this was vortexed
for 1 min and cell-associated fluorescence (10,000-30,000 cells per
sample) was detected using a CyAn ADP (DAKO) flow cytometer.
The % of PI positive cells was calculated using the following
equation = [% of PI positive cells (cells exposed to drugs) - % of
PI positive cells (cells untreated with drugs)].
Fluorescence microscopy
For confocal microscopy, 3.0610
4 cells were seeded onto glass
slides (Falcon, 4 well slides) and incubated for 24 h prior to
addition to particles. The cell number was set to ensure a cell
density comparable to the flow cytometry experiments and, in
order to keep all parameters affecting the experiment constant, the
same protocols were used for exposure to particles, sample
preparation and cell fixation. Thus, particle dispersions were
prepared in cMEM at room temperature just before addition to
the cells and, after particle exposure, medium was removed and all
samples were washed thrice with DPBS, fixed for 20 min with 4%
formalin solution neutral buffered, and the nucleus stained with
49,6-diamidino-2-phenylindole (DAPI blue). For F-Actin staining,
after exposure to one of the inhibitors, and fixation as described
above, cells were permeabilised with 0.1% Saponin (Sigma
Aldrich) for 5 min before staining the actin filaments by
incubation with Texas-red phalloidin (Invitrogen Corp.) for
20 min.
A confocal microscope (Carl Zeiss LSM 510 UVMETA,
Thornwood. NY) was used to capture images of the intracellular
environment and the sub-cellular localisation of the fluorescent
polymeric NPs. For multi-color microscopy, samples were excited
with 364 nm (blue channel), 488 nm (green channel), and 543 nm
(red channel) laser lines, and images were captured by multi-
tracking to avoid bleed-through between the fluorophores. To
achieve the necessary signal to noise ratio, while obtaining the
thinnest possible optical slices, the pinhole diameters were set to
less than 1 airy unit. After adjustment of the pinholes of both lasers
to obtain the same optical slices, the optimal optical section that
fulfilled our criteria was in the range 0.7–0.8 mm at 63X. The gain
and offset for the different channels were kept constant along the
full series of experiments in order to allow quantitative comparison
of the cell fluorescence intensities.
Supporting Information
Figure S1 Kinetics of uptake of 40 nm and 200 nm PS-
COOH NPs by HeLa cell line, as determined using flow
cytometry over 24 hrs. NP concentration is 20 mg/ml.
Averaged mean values of triplicate experiments are given. Inserts:
confocal images, showing 40 nm and 200 nm PS-COOH NPs
internalized by HeLa cells (Blue DAPI stained nuclei, FITC-
phalloidin stained actin filaments, and NPs in red. Magnification
63X). The scale bar corresponds to 20 mm.
(TIF)
Figure S2 Fluorescence emission of the PBS washes of
HeLa cells following exposure to NPs. PBS washes were
used to remove non internalised nanoparticles adhering on the cell
membrane prior to assessment of the cell fluorescence intensity by
flow cytometry. Similar data were obtained for the other cell lines.
From this data it is clear that 3 washes with PBS are sufficient to
ensure that the remaining cell fluorescence is from nanoparticles
that have been internalised by the cells.
(TIF)
Figure S3 Confocal images of a) 1321N1 and b) HeLa
cells, showing their F-actin morphology, after incuba-
tion with the different inhibitors at 46C for 2 h30 min
(Blue DAPI stained nuclei, Texas red-phalloidin stained
actin filaments. Magnification 63X). The scale bar corresponds
to 20 mm.
(TIF)
Figure S4 a) Effect of chlorpromazine on internalization of
transferrin into different cells. Cells were pre-treated with
chlorpromazine for 30 min, followed by 10 min of exposure to
Alexa fluorH 488 labelled transferrin in the presence of
chlorpromazine, before being fixed and analyzed by FACS. b)
Effect of genistein on internalization of cholera toxin B into A549
cells. Cells were pre-treated with genistein for 30 min, followed by
20 min of exposure to Alexa fluorH 488 labelled cholera toxin B in
the presence of genistein, before being fixed and analyzed by
FACS. Mean values and standard deviations of duplicate samples
are given. Results are reported as % uptake relative to the control
cells which were not treated with the inhibitor.
(TIF)
Acknowledgments
Access to, and use of, instrumentation of the UCD Conway Flow
Cytometry Core Facility and the UCD Conway Imaging Core Facility is
gratefully acknowledged.
Author Contributions
Conceived and designed the experiments: TdS JV IL AS KAD. Performed
the experiments: TdS. Analyzed the data: TdS JV IL SA KAD.
Contributed reagents/materials/analysis tools: TdS JV IL AS KAD.
Wrote the paper: TdS JV IL AS KAD.
Effects of Transport Inhibitors on NP’s Uptake
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e24438References
1. Allianz O (2004) Small sizes that matter: Opportunities and risks of
Nanotechnologies.
2. Farokhzad OC, Langer R (2009) Impact of Nanotechnology on Drug Delivery.
Acs Nano 3: 16–20.
3. Silva GA (2009) Nanotechnology applications and approaches for neuroregen-
eration and drug delivery to the central nervous system. Ann N Y Acad Sci 1199:
221–230.
4. Youan BBC (2008) Impact of nanoscience and nanotechnology on controlled
drug delivery. Nanomedicine 3: 401–406.
5. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and
diagnosis. Advanced Drug Delivery Reviews 54: 631–651.
6. Ferrari M (2005) Cancer nanotechnology: Opportunities and challenges. Nature
Reviews Cancer 5: 161–171.
7. Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, et al. (2011) Time and
space resolved uptake study of silica nanoparticles by human cells. Molecular
Biosystems 7: 371–378.
8. Watson P, Jones AT, Stephens DJ (2005) Intracellular trafficking pathways and
drug delivery: fluorescence imaging of living and fixed cells. Advanced Drug
Delivery Reviews 57: 43–61.
9. Marsh M, McMahon HT (1999) Cell biology - The structural era of endocytosis.
Science 285: 215–220.
10. Doherty GJ, McMahon HT (2009) Mechanisms of Endocytosis. Annual Review
of Biochemistry 78: 857–902.
11. Parton RG, Richards AA (2003) Lipid rafts and caveolae as portals for
endocytosis: New insights and common mechanisms. Traffic 4: 724–738.
12. Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis.
Nature Reviews Molecular Cell Biology 8: 603–612.
13. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature
422: 37–44.
14. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages.
Annual Review of Immunology 17: 593–623.
15. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, et al. (2002)
Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into
macrophages. Cell 110: 119–131.
16. Granseth B, Odermatt B, Royle SJ, Lagnado L (2006) Clathrin-mediated
endocytosis is the dominant mechanism of vesicle retrieval at hippocampal
synapses. Neuron 51: 773–786.
17. Granseth B, Odermatt B, Royle SJ, Lagnado L (2007) Clathrin-mediated
endocytosis: the physiological mechanism of vesicle retrieval at hippocampal
synapses. Journal of Physiology-London 585: 681–686.
18. Chen CL, Hou WH, Liu IH, Hsiao G, Huang SS, et al. (2009) Inhibitors of
clathrin-dependent endocytosis enhance TGF beta signaling and responses.
Journal of Cell Science 122: 1863–1871.
19. Huang FT, Khvorova A, Marshall W, Sorkin A (2004) Analysis of clathrin-
mediated endocytosis of epidermal growth factor receptor by RNA interference.
Journal of Biological Chemistry 279: 16657–16661.
20. Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent
internalization of particles via the pathways of clathrin-and caveolae-mediated
endocytosis. Biochemical Journal 377: 159–169.
21. Kirchhausen T (2000) CLATHRIN. Annual Review of Biochemistry 69:
699–727.
22. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzckalia T, et al.
(2005) Clathrin- and caveolin-1-independent endocytosis: entry of simian virus
40 into cells devoid of caveolae. Journal of Cell Biology 168: 477–488.
23. Orlandi PA, Fishman PH (1998) Filipin-dependent inhibition of cholera toxin:
Evidence for toxin internalization and activation through caveolae-like domains.
Journal of Cell Biology 141: 905–915.
24. Nabi IR, Le PU (2003) Caveolae/raft-dependent endocytosis. Journal of Cell
Biology 161: 673–677.
25. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nature Reviews
Molecular Cell Biology 1: 31–39.
26. Alonso MA, Millan J (2001) The role of lipid rafts in signalling and membrane
trafficking in T lymphocytes. Journal of Cell Science 114: 3957–3965.
27. Romer W, Berland L, Chambon V, Gaus K, Windschiegl B, et al. (2007) Shiga
toxin induces tubular membrane invaginations for its uptake into cells. Nature
450: 670-U673.
28. Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, et al. (2008) The
GTPase-Activating Protein GRAF1 Regulates the CLIC/GEEC Endocytic
Pathway. Current Biology 18: 1802–1808.
29. Schnitzer JE, Liu J, Oh P (1995) Endothelial caveolae have the molecular-
transport machinery for vesicle budding, docking, and fusion including VAMP,
NSF, SNAP, ANNEXINS, and GTPases. Journal of Biological Chemistry 270:
14399–14404.
30. Doherty GJ, Lundmark R (2009) GRAF1-dependent endocytosis. Biochemical
Society Transactions 37: 1061–1065.
31. Swanson JA, Watts C (1995) MACROPINOCYTOSIS. Trends in Cell Biology
5: 424–428.
32. Mercer J, Helenius A (2009) Virus entry by macropinocytosis. Nat Cell Biol 11:
510–520.
33. Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlba ¨ck B, et al. (2009)
Complete high-density lipoproteins in nanoparticle corona. Febs Journal 276:
3372–3381.
34. Cedervall T, Lynch I, Foy M, Bergga ˚rd T, Donnelly SC, et al. (2007) Detailed
Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles.
Angewandte Chemie 119: 5856–5858.
35. Yacobi NR, DeMaio L, Xie JS, Hamm-Alvarez SF, Borok Z, et al. (2008)
Polystyrene nanoparticle trafficking across alveolar epithelium. Nanomedicine-
Nanotechnology Biology and Medicine 4: 139–145.
36. Li W, Chen CY, Ye C, Wei TT, Zhao YL, et al. (2008) The translocation of
fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated
endocytosis. Nanotechnology 19.
37. Lai SK, Hida K, Man ST, Chen C, Machamer C, et al. (2007) Privileged
delivery of polymer nanoparticles to the perinuclear region of live cells via a non-
clathrin, non-degradative pathway. Biomaterials 28: 2876–2884.
38. Chono S, Tanino T, Seki T, Morimoto K (2007) Uptake characteristics of
liposomes by rat alveolar macrophages: influence of particle size and surface
mannose modification. Journal of Pharmacy and Pharmacology 59: 75–80.
39. Lu F, Wu SH, Hung Y, Mou CY (2009) Size Effect on Cell Uptake in Well-
Suspended, Uniform Mesoporous Silica Nanoparticles. Small 5: 1408–1413.
40. Luhmann T, Rimann M, Bitterman AG, Hall H (2008) Cellular uptake and
intracellular pathways of PLL-g-PEG-DNA nanoparticles. Bioconjugate Chem-
istry 19: 1907–1916.
41. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdo ¨rster G, McGrath JL
(2009) The influence of protein adsorption on nanoparticle association with
cultured endothelial cells. Biomaterials 30: 603–610.
42. Salvati A, Aberg C, dos Santos T, Varela J, Pinto P, et al. (2011) Experimental
and theoretical comparison of intracellular import of polymeric nanoparticles
and small molecules: Towards models of Uptake Kinetics. Nanomedicine:Na-
notechnology, Biology and Medicine in press.
43. Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape
dependence of gold nanoparticle uptake into mammalian cells. Nano Letters 6:
662–668.
44. Osaki F, Kanamori T, Sando S, Sera T, Aoyama Y (2004) A quantum dot
conjugated sugar ball and its cellular uptake on the size effects of endocytosis in
the subviral region. Journal of the American Chemical Society 126: 6520–6521.
45. Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, et al. (2008)
Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa
Cells. Macromolecular Bioscience 8: 1135–1143.
46. Huang M, Ma ZS, Khor E, Lim LY (2002) Uptake of FITC-chitosan
nanoparticles by a549 cells. Pharmaceutical Research 19: 1488–1494.
47. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, et al. (2009)
Improved cellular uptake of chitosan-modi fled PLGA nanospheres by A549
cells. International Journal of Pharmaceutics (Kidlington) 382: 198–204.
48. Gann H, Glaspell G, Garrad R, Wanekaya A, Ghosh K, et al. (2010) Interaction
of MnO and ZnO Nanomaterials with Biomedically Important Proteins and
Cells. Journal of Biomedical Nanotechnology 6: 37–42.
49. Bexiga MG, Varela JA, Wang F, Fenaroli F, Salvati A, et al. (2010) Cationic
nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human
astrocytoma cell line. Nanotoxicology;doi:10.3109/17435390.17432010.17539713.
50. Bayer N, Schober D, Prchla E, Murphy RF, Blaas D, et al. (1998) Effect of
bafilomycin A1 and nocodazole on endocytic transport in HeLa cells:
Implications for viral uncoating and infection. Journal of Virology 72:
9645–9655.
51. Vercauteren DNE, Vandenbroucke RE, Demeester J, De Smedt SC,
Braeckmans K, et al. (2008) The use of endocytic inhibitors to study uptake
of gene carriers. Journal of Controlled Release 132: e17–e18.
52. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al. (1987)
Genistein, a specific inhibitor of Tyrosine-specific protein-kinases. Journal of
Biological Chemistry 262: 5592–5595.
53. Sit KH, Bay BH, Wong KP (1993) Effect of genistein, a Tyrosine-specific
protein-kinase inhibitor, on cell rouding by pH upshifting. In Vitro Cellular &
Developmental Biology-Animal 29A: 395–402.
54. Qian ZM, Li HY, Sun HZ, Ho K (2002) Targeted drug delivery via the
transferrin receptor-mediated endocytosis pathway. Pharmacological Reviews
54: 561–587.
55. Liu SM, Magnusson KE, Sundqvist T (1993) Microtubules are involved in
transport of macromolecules by vesicles in clultured bovine aortic endothelial-
cells. Journal of Cellular Physiology 156: 311–316.
56. Goltz JS, Wolkoff AW, Novikoff PM, Stockert RJ, Satir P (1992) A role for
microtubules in sorting endocytic vesicles in rat hepatocytes. Proceedings of the
National Academy of Sciences of the United States of America 89: 7026–7030.
57. Kuchinskiene Z, Carlson LA (1982) Composition, concentration, and size of low
density lipoproteins and of subfractions of very low density lipoproteins from
serum of normal men and women. Journal of Lipid Research 23: 762–769.
58. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, et al. (2010) Serum
heat inactivation affects protein corona composition and nanoparticle uptake.
Biomaterials 31: 9511–9518.
59. Iacopetta BJ, Morgan EH (1983) The kinetics of transferrin endocytosis and iron
uptake from transferrin in rabbit reticulocytes. Journal of Biological Chemistry
258: 9108–9115.
60. Saraste J, Palade GE, Farquhar MG (1986) Temperature-sensitive steps in the
transport of secretory proteins through golgi-complex in exocrine pancreatic-
cells. Proceedings of the National Academy of Sciences of the United States of
America 83: 6425–6429.
Effects of Transport Inhibitors on NP’s Uptake
PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e2443861. Papakonstanti EA, Stournaras C (2008) Cell responses regulated by early
reorganization of actin cytoskeleton. Febs Letters 582: 2120–2127.
62. Gliem M, Heupel WM, Spindler V, Harms GS, Waschke J (2010) Actin
reorganization contributes to loss of cell adhesion in pemphigus vulgaris.
American Journal of Physiology-Cell Physiology 299: C606–C613.
63. Kabaso D, Shlomovitz R, Auth T, Lew VL, Gov NS (2010) Curling and Local
Shape Changes of Red Blood Cell Membranes Driven by Cytoskeletal
Reorganization. Biophysical Journal 99: 808–816.
64. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, et al.
(2010) The use of Inhibitors to Study Endocytic Pathways of Gene Carriers:
Optimization and Pitfalls. Mol Ther 18: 561–569.
65. Sato K, Nagai J, Mitsui N, Yumoto R, Takano M (2009) Effects of endocytosis
inhibitors on internalization of human IgG by Caco-2 human intestinal
epithelial cells. Life Sciences 85: 800–807.
66. Kitchens KM, Kolhatkar IB, Swaan PW, Ghandehari H (2008) Endocytosis
inhibitors prevent poly(amidoamine) dendrimer internalization and permeability
across Ceco-2 cells. Molecular Pharmaceutics 5: 364–369.
67. Andrei II (2008) Exocytosis and Endocytosis.
68. Torgersen ML, Skretting G, van Deurs B, Sandvig K (2001) Internalization of
cholera toxin by different endocytic mechanisms. Journal of Cell Science 114:
3737–3747.
Effects of Transport Inhibitors on NP’s Uptake
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24438